CLBT Valuation

Cellebrite DI Ltd

Add to Watchlist

Advanced Chart

14.320

-0.26(-1.783%)1D

Overview
Forecast
Valuation
Earnings

CLBT Relative Valuation

CLBT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLBT is overvalued; if below, it's undervalued.

Historical Valuation

Cellebrite DI Ltd (CLBT) is now in the Fair zone, suggesting that its current forward PE ratio of 30.92 is considered Fairly compared with the five-year average of 46.83. The fair price of Cellebrite DI Ltd (CLBT) is between 11.63 to 30.36 according to relative valuation methord.

Relative Value

Fair Zone

11.63-30.36

Current Price：14.58

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

9.35

P/B

Median3y

9.48

Median5y

4.82

3.83

FCF Yield

Median3y

3.09

Median5y

3.54

Competitors Valuation Multiple

The average P/S ratio for CLBT's competitors is 5.48, providing a benchmark for relative valuation. Cellebrite DI Ltd Corp (CLBT) exhibits a P/S ratio of 7.03, which is 28.32% above the industry average. Given its robust revenue growth of 20.06%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap